Chandler Robinson
Chief Executive Officer at Monopar Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Monopar Therapeutics Inc., 3 years.
Monopar Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Monopar Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Monopar Therapeutics Inc. | Option exercise | +14,056 | $30.00 | $421,680 |
| Sep 24, 2026 | Monopar Therapeutics Inc. | Option exercise | +15,000 | $14.00 | $210,000 |
| Sep 24, 2026 | Monopar Therapeutics Inc. | Open-market sale | −10,450 | $87.15 | $910,718 |
| Sep 24, 2026 | Monopar Therapeutics Inc. | Open-market sale | −9,638 | $87.96 | $847,758 |
| Sep 24, 2026 | Monopar Therapeutics Inc. | Open-market sale | −8,368 | $88.97 | $744,501 |
| Sep 24, 2026 | Monopar Therapeutics Inc. | Open-market sale | −600 | $89.79 | $53,874 |
| Jun 30, 2026 | Monopar Therapeutics Inc. | Option exercise | +12,873 | — | — |
| Jun 30, 2026 | Monopar Therapeutics Inc. | Shares withheld for tax | −4,084 | $92.59 | $378,138 |
| Mar 31, 2026 | Monopar Therapeutics Inc. | Option exercise | +6,732 | — | — |
| Mar 31, 2026 | Monopar Therapeutics Inc. | Shares withheld for tax | −1,972 | $54.79 | $108,046 |
| Dec 31, 2025 | Monopar Therapeutics Inc. | Option exercise | +8,724 | — | — |
| Dec 31, 2025 | Monopar Therapeutics Inc. | Shares withheld for tax | −2,558 | $65.30 | $167,037 |
| Sep 30, 2025 | Monopar Therapeutics Inc. | Option exercise | +8,726 | — | — |
| Sep 30, 2025 | Monopar Therapeutics Inc. | Shares withheld for tax | −2,646 | $81.67 | $216,099 |
| Jul 14, 2025 | Monopar Therapeutics Inc. | In-the-money exercise | +16,800 | $0.01 | $168 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.